Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syzygy Healthcare Solutions is a U.S. consumer healthcare company focused on women’s reproductive health. Its core commercial product is AfterPill, an FDA-authorized emergency contraceptive containing 1.5 mg levonorgestrel and marketed online as a lower-cost alternative to Plan B One-Step. The company appears to operate as a small private direct-to-consumer business rather than a traditional R&D-stage biotech, with commercial emphasis on accessibility, affordability, and mail-order distribution. Publicly available information suggests a narrow product portfolio centered on emergency contraception rather than a broad therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syzygy Healthcare Solutions.